ID

40357

Description

Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage; ODM derived from: https://clinicaltrials.gov/show/NCT01783717

Link

https://clinicaltrials.gov/show/NCT01783717

Keywords

Versions (1)
  1. 4/12/20 4/12/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 12, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypothalamic Obesity NCT01783717

English

Eligibility Hypothalamic Obesity NCT01783717

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. be between 18 and 55 years old;
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. greater than 6 months post-treatment (including surgery, radiotherapy or chemotherapy) of craniopharyngioma or other diseases in the hypothalamic region;
Description

Status post Timespan | Status post Operative Surgical Procedure Craniopharyngioma | Status post Therapeutic radiology procedure Craniopharyngioma | Status post Chemotherapy Craniopharyngioma | Status post Operative Surgical Procedure Hypothalamic Diseases | Status post Therapeutic radiology procedure Hypothalamic Diseases | Status post Chemotherapy Hypothalamic Diseases

Data type

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0872291
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0543467
UMLS CUI [2,3]
C0010276
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1522449
UMLS CUI [3,3]
C0010276
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0010276
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0543467
UMLS CUI [5,3]
C0020655
UMLS CUI [6,1]
C0231290
UMLS CUI [6,2]
C1522449
UMLS CUI [6,3]
C0020655
UMLS CUI [7,1]
C0231290
UMLS CUI [7,2]
C0392920
UMLS CUI [7,3]
C0020655
3. bmi≧28kg/m2 and/or diabetes mellitus;
Description

Body mass index | Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1]
C1305855
UMLS CUI [2]
C0011849
4. greater than 3 months after adequate replacement therapy for hypothalamic-pituitary-adrenal (hpa) axis and hypothalamic-pituitary-thyroid (hpt) axis;
Description

Status post Timespan | Status post Replacement Therapy HPA axis | Status post Replacement Therapy HPT axis

Data type

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0872291
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0559956
UMLS CUI [2,3]
C0087111
UMLS CUI [2,4]
C0597719
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0559956
UMLS CUI [3,3]
C0087111
UMLS CUI [3,4]
C0814031
5. sign informed consent document.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. less than 6 months post surgery or radiotherapy or chemotherapy for craniopharyngioma or other diseases in the hypothalamic region;
Description

Status post Timespan | Status post Operative Surgical Procedure Craniopharyngioma | Status post Therapeutic radiology procedure Craniopharyngioma | Status post Chemotherapy Craniopharyngioma | Status post Operative Surgical Procedure Hypothalamic Diseases | Status post Therapeutic radiology procedure Hypothalamic Diseases | Status post Chemotherapy Hypothalamic Diseases

Data type

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0872291
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0543467
UMLS CUI [2,3]
C0010276
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1522449
UMLS CUI [3,3]
C0010276
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0010276
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0543467
UMLS CUI [5,3]
C0020655
UMLS CUI [6,1]
C0231290
UMLS CUI [6,2]
C1522449
UMLS CUI [6,3]
C0020655
UMLS CUI [7,1]
C0231290
UMLS CUI [7,2]
C0392920
UMLS CUI [7,3]
C0020655
2. inadequate replacement for the hpa axis and hpt axis or undertaking adjustments of the kind or dose of the substitutive medicine;
Description

Replacement Inadequate HPA axis | Replacement Inadequate HPT axis

Data type

boolean

Alias
UMLS CUI [1,1]
C0559956
UMLS CUI [1,2]
C0205412
UMLS CUI [1,3]
C0597719
UMLS CUI [2,1]
C0559956
UMLS CUI [2,2]
C0205412
UMLS CUI [2,3]
C0814031
3. use of weight loss drugs or initiation of a weight loss program within past 3 months;
Description

Weight-Loss Agents | Initiation Weight Reduction Program

Data type

boolean

Alias
UMLS CUI [1]
C0376606
UMLS CUI [2,1]
C1704686
UMLS CUI [2,2]
C3179079
4. use of glp-1 agonists or analogues or dipeptidyl peptidase iv (dpp-iv) inhibitors within past 3 months;
Description

GLP-1 Receptor Agonist | GLP-1 Mimetics | Dipeptidyl-Peptidase IV Inhibitors

Data type

boolean

Alias
UMLS CUI [1]
C2917359
UMLS CUI [2]
C3273809
UMLS CUI [3]
C1827106
5. history of bariatric surgery;
Description

Bariatric Surgery

Data type

boolean

Alias
UMLS CUI [1]
C1456587
6. diagnosed with simple obesity or diabetes mellitus prior to the hypothalamic disorders, and those diagnosed with type 1 diabetes mellitus;
Description

Simple obesity | Diabetes Mellitus | Status pre- Hypothalamic Diseases | Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0451819
UMLS CUI [2]
C0011849
UMLS CUI [3,1]
C0332152
UMLS CUI [3,2]
C0020655
UMLS CUI [4]
C0011854
7. with end-stage-renal diseases or history of kidney transplant or complicated with acute/chronic kidney failure (gfr≦30ml/min);
Description

Kidney Failure, Chronic | Kidney Transplantation | Kidney Failure with Complication | Chronic Kidney Failure with Complication | Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0022671
UMLS CUI [3,1]
C0035078
UMLS CUI [3,2]
C0332287
UMLS CUI [3,3]
C0009566
UMLS CUI [4,1]
C0022661
UMLS CUI [4,2]
C0332287
UMLS CUI [4,3]
C0009566
UMLS CUI [5]
C0017654
8. history of inflammatory bowel diseases or gastroparesis or other gastric mortility problems;
Description

Inflammatory Bowel Diseases | Gastroparesis | Abnormal gastric motility

Data type

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0152020
UMLS CUI [3]
C0232574
9. history of pancreatitis or chronic cholecystitis;
Description

History of pancreatitis | Chronic cholecystitis

Data type

boolean

Alias
UMLS CUI [1]
C3887021
UMLS CUI [2]
C0085694
10. history of allergic reaction to exenatide or other medication components;
Description

Allergic Reaction Exenatide | Allergic Reaction Pharmaceutical Preparation Component

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0167117
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C1705248
11. undertaking warfarin;
Description

Warfarin

Data type

boolean

Alias
UMLS CUI [1]
C0043031
12. pregnant or lactating women;
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
13. are participating in, or have participated in other drug clinical trials within past 3 months.
Description

Study Subject Participation Status | Clinical Trial | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
UMLS CUI [3]
C0013230
Back to the top of the page

Similar models

Eligibility Hypothalamic Obesity NCT01783717

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. be between 18 and 55 years old;
boolean
C0001779 (UMLS CUI [1])
Status post Timespan | Status post Operative Surgical Procedure Craniopharyngioma | Status post Therapeutic radiology procedure Craniopharyngioma | Status post Chemotherapy Craniopharyngioma | Status post Operative Surgical Procedure Hypothalamic Diseases | Status post Therapeutic radiology procedure Hypothalamic Diseases | Status post Chemotherapy Hypothalamic Diseases
Item
2. greater than 6 months post-treatment (including surgery, radiotherapy or chemotherapy) of craniopharyngioma or other diseases in the hypothalamic region;
boolean
C0231290 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
C0010276 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C0010276 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0010276 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0543467 (UMLS CUI [5,2])
C0020655 (UMLS CUI [5,3])
C0231290 (UMLS CUI [6,1])
C1522449 (UMLS CUI [6,2])
C0020655 (UMLS CUI [6,3])
C0231290 (UMLS CUI [7,1])
C0392920 (UMLS CUI [7,2])
C0020655 (UMLS CUI [7,3])
Body mass index | Diabetes Mellitus
Item
3. bmi≧28kg/m2 and/or diabetes mellitus;
boolean
C1305855 (UMLS CUI [1])
C0011849 (UMLS CUI [2])
Status post Timespan | Status post Replacement Therapy HPA axis | Status post Replacement Therapy HPT axis
Item
4. greater than 3 months after adequate replacement therapy for hypothalamic-pituitary-adrenal (hpa) axis and hypothalamic-pituitary-thyroid (hpt) axis;
boolean
C0231290 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0559956 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0597719 (UMLS CUI [2,4])
C0231290 (UMLS CUI [3,1])
C0559956 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C0814031 (UMLS CUI [3,4])
Informed Consent
Item
5. sign informed consent document.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Status post Timespan | Status post Operative Surgical Procedure Craniopharyngioma | Status post Therapeutic radiology procedure Craniopharyngioma | Status post Chemotherapy Craniopharyngioma | Status post Operative Surgical Procedure Hypothalamic Diseases | Status post Therapeutic radiology procedure Hypothalamic Diseases | Status post Chemotherapy Hypothalamic Diseases
Item
1. less than 6 months post surgery or radiotherapy or chemotherapy for craniopharyngioma or other diseases in the hypothalamic region;
boolean
C0231290 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
C0010276 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C0010276 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0010276 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0543467 (UMLS CUI [5,2])
C0020655 (UMLS CUI [5,3])
C0231290 (UMLS CUI [6,1])
C1522449 (UMLS CUI [6,2])
C0020655 (UMLS CUI [6,3])
C0231290 (UMLS CUI [7,1])
C0392920 (UMLS CUI [7,2])
C0020655 (UMLS CUI [7,3])
Replacement Inadequate HPA axis | Replacement Inadequate HPT axis
Item
2. inadequate replacement for the hpa axis and hpt axis or undertaking adjustments of the kind or dose of the substitutive medicine;
boolean
C0559956 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0597719 (UMLS CUI [1,3])
C0559956 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
C0814031 (UMLS CUI [2,3])
Weight-Loss Agents | Initiation Weight Reduction Program
Item
3. use of weight loss drugs or initiation of a weight loss program within past 3 months;
boolean
C0376606 (UMLS CUI [1])
C1704686 (UMLS CUI [2,1])
C3179079 (UMLS CUI [2,2])
GLP-1 Receptor Agonist | GLP-1 Mimetics | Dipeptidyl-Peptidase IV Inhibitors
Item
4. use of glp-1 agonists or analogues or dipeptidyl peptidase iv (dpp-iv) inhibitors within past 3 months;
boolean
C2917359 (UMLS CUI [1])
C3273809 (UMLS CUI [2])
C1827106 (UMLS CUI [3])
Bariatric Surgery
Item
5. history of bariatric surgery;
boolean
C1456587 (UMLS CUI [1])
Simple obesity | Diabetes Mellitus | Status pre- Hypothalamic Diseases | Diabetes Mellitus, Insulin-Dependent
Item
6. diagnosed with simple obesity or diabetes mellitus prior to the hypothalamic disorders, and those diagnosed with type 1 diabetes mellitus;
boolean
C0451819 (UMLS CUI [1])
C0011849 (UMLS CUI [2])
C0332152 (UMLS CUI [3,1])
C0020655 (UMLS CUI [3,2])
C0011854 (UMLS CUI [4])
Kidney Failure, Chronic | Kidney Transplantation | Kidney Failure with Complication | Chronic Kidney Failure with Complication | Glomerular Filtration Rate
Item
7. with end-stage-renal diseases or history of kidney transplant or complicated with acute/chronic kidney failure (gfr≦30ml/min);
boolean
C0022661 (UMLS CUI [1])
C0022671 (UMLS CUI [2])
C0035078 (UMLS CUI [3,1])
C0332287 (UMLS CUI [3,2])
C0009566 (UMLS CUI [3,3])
C0022661 (UMLS CUI [4,1])
C0332287 (UMLS CUI [4,2])
C0009566 (UMLS CUI [4,3])
C0017654 (UMLS CUI [5])
Inflammatory Bowel Diseases | Gastroparesis | Abnormal gastric motility
Item
8. history of inflammatory bowel diseases or gastroparesis or other gastric mortility problems;
boolean
C0021390 (UMLS CUI [1])
C0152020 (UMLS CUI [2])
C0232574 (UMLS CUI [3])
History of pancreatitis | Chronic cholecystitis
Item
9. history of pancreatitis or chronic cholecystitis;
boolean
C3887021 (UMLS CUI [1])
C0085694 (UMLS CUI [2])
Allergic Reaction Exenatide | Allergic Reaction Pharmaceutical Preparation Component
Item
10. history of allergic reaction to exenatide or other medication components;
boolean
C1527304 (UMLS CUI [1,1])
C0167117 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C1705248 (UMLS CUI [2,3])
Warfarin
Item
11. undertaking warfarin;
boolean
C0043031 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
12. pregnant or lactating women;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status | Clinical Trial | Investigational New Drugs
Item
13. are participating in, or have participated in other drug clinical trials within past 3 months.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial